Publicacions
- Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review
Nogues-Castell, Javier; Feu-Basilio, Silvia; Felguera Garcia, Oscar; (4/7) de Larrea, Carlos Fernandez; Oliver-Caldes, Aina; Ponz, Olga Balague; Fassi, Jessica Matas. 2023. Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review. Frontiers in Oncology. 13. ISSN 2234-943X. WOS (0)
Emerging Learnings in Cell Therapy
- Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia
Moreno, David F.; (2/2) de Larrea, Carlos Fernandez (AC). 2023. Clinical Implications of Genomic Profile in Waldenstrom Macroglobulinemia. Hematology-Oncology Clinics of North America. W B SAUNDERS CO-ELSEVIER INC. 37-4, pp.659-670. ISSN 0889-8588. WOS (0)
Hematology/Oncology Clinics of North America
- Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
Oliver-Caldes, Aina; Gonzalez-Calle, Veronica; Cabanas, Valentin; et al; (31/31) de Larrea, Carlos Fernandez (AC). 2023. Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CART-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA- HCB-01): a single-arm, multicentre, academic pilot study. Lancet Oncology. ELSEVIER SCIENCE INC. 24-8, pp.913-924. ISSN 1470-2045. WOS (1)
The Lancet Oncology
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
San-Miguel, Jesus; Dhakal, Binod; Yong, Kwee; et al; Einsele, Hermann; (7/43) de Larrea, Carlos Fernandez. 2023. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma. New England Journal of Medicine. MASSACHUSETTS MEDICAL SOC. ISSN 0028-4793. WOS (8)
The New England Journal of Medicine
- Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis
Moreno-Castano, Ana Belen; Fernandez, Sara; Ventosa, Helena; et al; Diaz-Ricart, Maribel; (9/18) Fernandez de Larrea, Carlos. 2023. Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis. Journal for Immunotherapy of Cancer. BMJ PUBLISHING GROUP. 11-4. ISSN 2051-1426. WOS (0)
Journal for ImmunoTherapy of Cancer
- Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström’s Macroglobulinemia on Management of Waldenström’s Macroglobulinemia Related Amyloidosis
Merlini, Giampaolo; Sarosiek, Shayna; Benevolo, Giulia; et al; Minnema, Monique C.; (8/11) de Larrea, Carlos Fernandez. 2023. Report of Consensus Panel 6 from the 11 th International Workshop on Waldenstrom’s Macroglobulinemia on Management of Waldenstrom’s Macroglobulinemia Related Amyloidosis. Seminars in Hematology. W B SAUNDERS CO-ELSEVIER INC. 60-2, pp.113-117. ISSN 0037-1963. WOS (0)
Seminars in Hematology
- Report of Consensus Panel 3 from the 11th International workshop on Waldenström’s Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström’s Macroglobulinemia
Garcia-Sanz, Ramon; Varettoni, Marzia; Jimenez, Cristina; et al; Hunter, Z. R.; (17/22) De Larrea, C. Fernandez. 2023. Report of Consensus Panel 3 from the 11th International workshop on Waldenstrom’s Macroglobulinemia: Recommendations for molecular diagnosis in Waldenstrom’s Macroglobulinemia. Seminars in Hematology. W B SAUNDERS CO-ELSEVIER INC. 60-2, pp.90-96. ISSN 0037-1963. WOS (0)
Seminars in Hematology
- The Progress Test of the European Hematology Association: A New Tool for Continuous Learning
Wondergem, Marielle J.; Almeida, Antonio; Brolin, Janaki; et al; Birgegard, Gunnar; (4/11) Fernandez de Larrea, Carlos. 2022. The Progress Test of the European Hematology Association: A New Tool for Continuous Learning. Hemasphere. 6-12. ISSN 2572-9241. WOS (0)
HemaSphere
- Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
David F. Moreno, Mónica López-Guerra, Sara Paz, Aina Oliver-Caldés, Mari-Pau Mena, Juan G. Correa, Anthony M. Battram, Miguel Osuna, Alfredo Rivas-Delgado, Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Natalia Tovar, María Teresa Cibeira, Raquel Jiménez-Segura, Joan Bladé, Laura Rosiñol, Dolors Colomer, Carlos Fernández de Larrea
British Journal of Haematology
- CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Rodriguez-Marquez, Paula; Calleja-Cervantes, Maria E; Serrano, Guillermo; et al; Prosper, Felipe; (30/33) Fernandez de Larrea, Carlos. 2022. CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.Science advances. 8-39, pp.eabo0514. ISSN 2375-2548. WOS (1)
Science Advances
- Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
Jimenez-Segura, Raquel; Rosinol, Laura; Teresa Cibeira, Ma; et al; Blade, Joan; (4/10) Fernandez de Larrea, Carlos. 2022. Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution. Blood Cancer Journal. 12-9. ISSN 2044-5385. WOS (0)
Blood Cancer Journal
- T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
Anthony M. Battram, Aina Oliver-Caldés, Maria Suárez-Lledó,Miquel Lozano, Miquel Bosch i Crespo, Núria Martínez-Cibrián, Joan Cid, David F. Moreno,Luis Gerardo Rodríguez-Lobato, Alvaro Urbano-Ispizua, and Carlos Fernández de Larrea
Molecular Therapy. Methods & Clinical Development
- Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma
Oliver-Caldes, Aina; Soler-Perromat, Juan Carlos; Lozano, Ester; et al; (18/18) de Larrea, Carlos Fernandez (AC). 2022. Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma. Frontiers in Oncology. 12. ISSN 2234-943X. WOS (0)
Applied Precision Medicine in Plasma Cell Dyscrasias
- Diagnostic Potential of the Serological Response to Synthetic Peptides from Mycobacterium tuberculosis Antigens for Discrimination Between Active and Latent Tuberculosis Infections
Araujo, Zaida; de Waard, Jacobus H.; Camargo, Milena; Lopez-Ramos, Juan Ernesto; (5/7) de Larrea, Carlos Fernandez; Vanegas, Magnolia; Patarroyo, Manuel A.2022. Diagnostic Potential of the Serological Response to Synthetic Peptides from Mycobacterium tuberculosis Antigens for Discrimination Between Active and Latent Tuberculosis Infections. International Journal of Peptide Research and Therapeutics. 28-3. ISSN 1573-3149. WOS (0)
International Journal of Peptide Research and Therapeutics
- CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma
Roncador, Giovanna; Punet-Ortiz, Joan; Maestre, Lorena; et al; Engel, Pablo; (13/14) Fernandez de Larrea, Carlos. 2022. CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma. Cancers. 14-9. ISSN 2072-6694. WOS (0)
B Cell Malignancies
- Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
Ortiz-Maldonado, Valentín; Rives, Susana; Español-Rego, Marta; et al; Delgado, Julio; (29/37) Fernández de Larrea, Carlos. 2021. Factors associated with the clinical outcome of patients with relapsed/refractory CD19 + acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.Journal for immunotherapy of cancer. 9-12. ISSN 2051-1426. WOS (3)
Journal for ImmunoTherapy of Cancer
- First report of CART treatment in AL amyloidosis and relapsed/refractory multiple mieloma
Oliver-Caldes, Aina; Jiménez, Raquel; Español-Rego, Marta; et al; (28/28) Fernández de Larrea, Carlos (AC). 2021. First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma.Journal for Immunotherapy of Cancer. 9-12, pp.e003783. ISSN 2051-1426. WOS (2)
Journal for ImmunoTherapy of Cancer
- Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Carlos Fernández de Larrea, Robert Kyle, Laura Rosiñol, Bruno Paiva, Monika Engelhardt, Saad Usmani, Jo Caers, Wilson Gonsalves, Fredrik Schjesvold, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin Kaiser, Jesús San Miguel, Joan Bladé, S. Vincent Rajkumar, Maria Victoria Mateos
Blood Cancer Journal
- Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease
Isola, Ignacio; Brasó-Maristany, Fara; Moreno, David F; et al; (14/14) Fernández de Larrea, Carlos (AC). 2021. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.Frontiers in Immunology. 12-792609. ISSN 1664-3224. WOS (0)
The Bone/Bone Marrow Microenvironment
- 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; et al; San Miguel, Jesus; (9/24) de Larrea, Carlos Fernandez. 2021. 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde. Haematologica. 106-11, pp.2799-2812. ISSN 0390-6078. WOS (7)
European Myeloma Network
- Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
Moreno, David F; Rosiñol, Laura; Cibeira, María Teresa; Bladé, Joan; (5/5) Fernández de Larrea, Carlos (AC). 2021. Treatment of Patients with Monoclonal Gammopathy of Clinical Significance.Cancers. 13-20, pp.Art. num. 5131. ISSN 2072-6694. WOS (0)
Emerging Treatment Strategies for Multiple Myeloma
- Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period
Rodríguez-Lobato, Luis Gerardo; Pereira, Arturo; (3/10) Fernández de Larrea, Carlos; et al; Bladé, Joan. 2022. Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.British Journal of Haematology. 196-3, pp.649-659. ISSN 0007-1048. WOS (0)
British Journal of Haematology
- Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Isola, Ignacio; Moreno, David F; Moga, Esther; et al; (15/15) Fernández de Larrea, Carlos (AC). 2021. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.Annals of Hematology. 100-12, pp.2997-3005. ISSN 0939-5555. WOS (1)
Annals of Hematology
- Predictors of return to work after autologous stem cell transplantation in patients with multiple mieloma
Granell, Miquel; Senin, Alicia; Barata, Anna; et al; Study Myeloma Amyloidosis Cataloni; (16/19) Fernandez de Larrea, Carlos. 2021. Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma. Bone Marrow Transplantation. SPRINGERNATURE. 56-12, pp.2904-2910. ISSN 0268-3369. WOS (0)
Bone Marrow Transplantation
- IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation
Battram, Anthony M; Bachiller, Mireia; Lopez, Victor; (4/6) Fernández de Larrea, Carlos (AC); Urbano-Ispizua, Alvaro; Martín-Antonio, Beatriz. 2021. IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation.Cancers. 13-14, pp.Art. Num.3534. ISSN 2072-6694. WOS (5)
Cancer Immunology and Immunotherapy
- ESAT-6 and Ag85A Synthetic Peptides as Candidates for an Immunodiagnostic Test in Children with a Clinical Suspicion of Tuberculosis
Araujo, Zaida; (2/9) Fernández de Larrea, Carlos (AC); López, Diana; et al; Patarroyo, Manuel A. 2021. ESAT-6 and Ag85A Synthetic Peptides as Candidates for an Immunodiagnostic Test in Children with a Clinical Suspicion of Tuberculosis. Disease Markers. 2021, pp.6673250-6673250. ISSN 0278-0240. WOS (0)
Hindawi
- Kidney Transplantation in Monoclonal Immunoglobulin Deposition Disease: A Report of 6 Cases
Molina-Andújar, Alicia; Tovar, Natalia; Cuadrado, Elena; et al; Quintana, Luis F; (13/14) Fernández de Larrea, Carlos. 2021. Kidney Transplantation in Monoclonal Immunoglobulin Deposition Disease: A Report of 6 Cases.American Journal of Kidney Diseases : the official journal of the National Kidney Foundation. 78-5, pp.755-759. ISSN 0272-6386. WOS (0)
American Journal of Kidney Diseases
- Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
Moreno, David F; Pereira, Arturo; Tovar, Natalia; et al; (17/17) Fernandez de Larrea, Carlos (AC). 2021. Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.Cancers. 13-9, pp.Ary. Num. 2055. ISSN 2072-6694. WOS (3)
MDPI
- Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Rosiñol, Laura; Beksac, Meral; Zamagni, Elena; et al; Bladé, Joan; (13/38) Fernández de Larrea, Carlos. 2021. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.British Journal of Haematology. 194-3, pp.496-507. ISSN 0007-1048. WOS (22)
British Journal of Haematology
- Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe-Herranz, Mireia; Klein-Gonzalez, Nela; Rodriguez-Lobato, Luis Gerardo; Juan, Manel; (5/5) Fernandez de Larrea, Carlos (AC). 2021. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure.International Journal of Molecular Sciences. 22-3. ISSN 1422-0067. WOS (11)
Microbiota and Cancer
- Consenso del Grupo Latinoamericano de estudio de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de Pandemia SARS CoV-2 / COVID 19
Martínez-Cordero, Humberto; Martínez-Correa, Lina María; Ospina, Juan Alejandro; et al; Zamora, Marcela; (8/17) Fernández de Larrea, Carlos. 2020. Consensus of the Latin American Study Group on Multiple Myeloma (MM) GELAMM for the management of MM in a state of Pandemic SARS-CoV-2 / COVID-19. Revista Colombiana de Cancerología. 24-suppl 1, pp.227-240. ISSN 0123-9015. WOS (0)
Revista Colombiana de Cancerología
- Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma
Mozas, Pablo; Rivero, Andrea; Rivas-Delgado, Alfredo; et al; Lopez-Guillermo, Armando; (14/20) Fernandez de Larrea, Carlos. 2021. Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.British Journal of Haematology. WILEY. 193-2, pp.299-306. ISSN 1365-2141. WOS (1)
British Journal of Haematology
- The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever
Rodriguez-Lobato, Luis-Gerardo; Martinez-Roca, Alexandra; Castano-Diez, Sandra; et al; Fernandez-Aviles, Francesc; (10/26) Fernandez de Larrea, Carlos. 2020. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.Plos One. Public Library Science. 15-11. ISSN 1932-6203. WOS (1)
PLOS
- A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
Tam, Constantine S; Opat, Stephen; D’Sa, Shirley; et al; Dimopoulos, Meletios; (16/33) Fernandez de Larrea, Carlos. 2020. A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstrom macroglobulinemia: the ASPEN study.Blood. 136-18, pp.2038-2050. ISSN 1528-0020. WOS (120)
The American Society of Hematology
- Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
Martinez-Lopez, Joaquin; Mateos, Maria-Victoria; Encinas, Cristina; et al; San-Miguel, Jesus; (14/25) Fernandez de Larrea, Carlos. 2020. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.Blood Cancer Journal. 10-10, pp.103. ISSN 2044-5385. WOS (38)
Blood Cancer Journal
- International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Mateos, Maria-Victoria; Kumar, Shaji; Dimopoulos, Meletios A.; et al; San-Miguel, Jesus; (7/29) Fernandez De Larrea, Carlos. 2020. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).Blood Cancer Journal. 10-10. ISSN 2044-5385. WOS (55)
Blood Cancer Journal
- Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple mieloma
Oriol, Albert; Ibarra, Gladys; Abella, Eugenia; et al; GEMMAC Study Grp; (12/14) Fernandez, Carlos. 2021. Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma.Leukemia & Lymphoma. Taylor & Francis. 62-1, pp.125-135. ISSN 1042-8194. WOS (0)
Leukemia & Lymphoma
- Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, Khong Y Ng, Yunxin Chen, William D Godfrey, Terence J Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J Brentjens, Eric L Smith
Blood Cancer Discovery
- Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
Ester Lozano; Mari-Pau Mena; Tania Díaz; Beatriz Martin-Antonio; Sheila León; Luis-Gerardo Rodríguez-Lobato; Aina Oliver-Caldés; Maria Teresa Cibeira; Joan Bladé; Aleix Prat; Laura Rosiñol; Carlos Fernández de Larrea
Clinical Cancer Research
- Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)
Guillen, Elena; Montagud-Marrahi, Enrique; Rodriguez, Diana M.; et al; Quintana, Luis F.; (9/11) Fernandez de Larrea, Carlos. 2020. Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL). Annals of Hematology. Springer. 99-12, pp.2961-2962. ISSN 0939-5555. WOS (1)
Annals of Hematology
- CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
Gerardo Rodriguez-Lobato, Luis; Ganzetti, Maya; (3/6) Fernandez de Larrea, Carlos; Hudecek, Michael; Einsele, Hermann; Danhof, Sophia. 2020. CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions.Frontiers in Oncology. 10-1243. ISSN 2234-943X. WOS (38)
CAR T-Cell Therapies in Hematologic Tumors
- Supportive Care in AL Amyloidosis
Teresa Cibeira, M.; Ortiz-Perez, Jose T.; Quintana, Luis F.; (4/6) Fernadez de Larrea, Carlos; Tovar, Natalia; Blade, Joan. 2020. Supportive Care in AL Amyloidosis. Acta Haematologica. 143-4, pp.335-342. ISSN 0001-5792. WOS (8)
Acta Haematologica
- Complement as the enabler of carfilzomib-induced thrombotic microangiopathy
Blasco, Miquel; Martínez-Roca, Alexandra; Rodríguez-Lobato, Luis G; et al; Palomo, Marta; (11/19) Fernández de Larrea, Carlos. 2021. Complement as the enabler of carfilzomib-induced thrombotic microangiopathy. British Journal of Haematology. 193-1, pp.181—187-181—187. ISSN 0007-1048. WOS (9)
British Journal of Haematology
- Future prospects of chimeric antigen receptor T-cell therapy for multiple mieloma
(1/4) De Larrea, C.F.; Landgren, O.; Mailankody, S.; Smith, E.2019. Future prospects of chimeric antigen receptor T-cell therapy for multiple myeloma. Advances in Cell and Gene Therapy. 00, pp.e72. ISSN 2573-8461.
ADVANCES IN CELL AND GENE THERAPY
- GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
Smith, EL.; Harrington, K.; Staehr, M.; et al; Brentjens, RJ.; (14/26) de Larrea, C.F.2019. GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.Science Translational Medicine. 11-485, pp.eaau7746. ISSN 1946-6242. WOS (126)
SCIENCE TRANSLATIONAL MEDICINE
- Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple mieloma
Jiménez- Segura, R.; Granell, M.; Gironella, M.; et al; Rosiñol, L.; (12/17) de Larrea, C.F.2019. Pomalidomide-Dexamethasone for treatment of soft tissue plasmacytomas in patients with relapsed / refractory multiple myeloma. European Journal of Haematology. 102-5, pp.389-394. ISSN 0902-4441. WOS (14)
European Journal of Haematology
- Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis
Gutiérrez- García, G.; Cibeira, M.T.; Rovira, M.; et al; Bladé, J.; (4/22) de Larrea, C.F.2019. Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.Bone Marrow Transplantation. 54-8, pp.1295-1303. ISSN 0268-3369. WOS (4)
Bone Marrow Transplantation
- Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, Ma Teresa Cibeira, Laura Magnano, Natalia Tovar, Luis-Gerardo Rodríguez-Lobato, Xavier Calvo, Juan I. Aróstegui, Tania Díaz, Ester Lozano, María Rozman, Jordi
Leukemia